Advances in LC platforms for drug discovery

Raul Nicoli University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

, PhD,

Sophie Martel University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

, PhD,

Serge Rudaz University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

, PhD,

Jean-Luc Wolfender University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

Jean-Luc Veuthey University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

Pierre-Alain Carrupt University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

Davy Guillarme University of Geneva, University of Lausanne, School of Pharmaceutical Sciences, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland +41 22 379 33 59; +41 22 379 33 60; [email protected]

, PhD show all

Abstract

Importance of the field: The major application areas of liquid chromatography (LC) in modern drug discovery are the identification and structural characterization of new potential lead compounds from natural and/or synthetic sources and the determination of their physico-chemical and pharmacokinetic properties.

Areas covered in this review: Significant advances in terms of LC platforms achieved in the last 5 years are highlighted in this review. Special attention is paid to novel LC strategies used in the discovery of new bioactive molecules and the determination of lipophilicity, pK_a values, passive drug permeability and in vitro metabolism of new chemical entities.

What the reader will gain: Many improvements were achieved in terms of LC instrumentation, columns technology and analytes detection to attain ultra-fast and/or high-resolution chromatographic separations. These advances are particularly beneficial to face the complexity and high number of samples studied in the early phases of the discovery process. Advantages and drawbacks of each strategy are discussed.

Take home message: LC and ultra high pressure liquid chromatography coupled with mass spectrometry detection constitute the most promising strategies to achieve high-throughput and/or high-resolution analyses in a drug discovery environment.

Keywords::

Notes

This box summarizes key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Advances in LC platforms for drug discovery

Information for

Open access

Opportunities

Help and information

Advances in LC platforms for drug discovery

Abstract

Notes

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature